TIM3+FOXP3+regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer

T cells. Collectively, our data indicate that TIM3 marks highly suppressive tissue-resident Tregs that play an important role in shaping the antitumor immune response in situ, increasing the value of TIM3-targeting therapeutic strategies against cancer.